Key Dates

Related Announcements

• February 3, 2022 - Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed). See NOFO PAR-22-101.
• April 13, 2023 - Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed). See NOFO PAR-23-159.

Issued by

National Center for Advancing Translational Sciences (NCATS)

Purpose

Effective immediately, the Funding Opportunity Announcement PAR-22-101 “Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)” is terminated. Applications submitted to PAR-22-101 will not be reviewed. NIH has reissued this Notice of Funding Opportunity as PAR-23-159 “Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)”.

Inquiries

Please direct all inquiries to:

Alice Chen Grady, MD
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-827-2015
Email: [email protected]